Specimen Collection Study to Evaluate Biomarkers in Subjects with Cancer
            Read More 
          
       
      
      
        
            
            
            ComboMATCH Treatment Trial E4: Nilotinib and Paclitaxel in Patients with Prior Taxane-Treated Solid Tumors (NCT #05554341)
            Read More 
          
       
      
      
        
            
            
            Phase II Study of Paclitaxel (NSC #673089) + Ipatasertib (NSC #781451) in Taxane-Refractory Participants with AKT-Altered Advanced Non-Breast Solid Tumors
            Read More 
          
       
      
      
        
            
            
            Molecular Analysis for Combination Therapy Choice (ComboMATCH)
            Read More 
          
       
      
      
        
            
            
            S2012: Randomized Phase II/III Trial of First Line Platinum/Etoposide with or without Atezolizumab (NSC#783608) in Patients with Poorly Differentiated Extrapulmonary Small Cell Neuroendocrine Carcinomas (NEC)
            Read More 
          
       
      
      
        
            
            
            DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors
            Read More 
          
       
      
      
        
            
            
            A151804: Establishment of a national biorepository to advance studies of immune-related adverse events
            Read More